This past December, the FDA approved both zoliflodacin and gepotidacin for this sexually transmitted infection marking a significant advance amid rising antibiotic resistance. Here is an overview of the antibiotics.
Jill O'Donnell, PharmD, BCPS, BCGP
Advertisement
O'Donnell is a pharmacist with board certification in pharmacotherapy and geriatrics. She has experience in hospital and outpatient antimicrobial stewardship and infectious disease.
Articles by Jill O'Donnell, PharmD, BCPS, BCGP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
FDA Clears First At-Home Diagnostic for RSV, Influenza, and COVID-19 in Adults, Young Infants
2
CDC ACIP Workgroup Reviewing FDA-Approved HPV Vaccines
3
Congress Preserves Domestic HIV Funding in Final FY2026 Spending Deal
4
UTI Treatment: Tailoring Patient Education and the Role of Insurance Payers
5